MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-14-2024
Country |
 USA |
IPO year |
2014 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
2.61 M |
Market Cap[1] |
$ 313 K |
EBITDA (LTM) |
$ -45.6 M |
P/E (LTM) |
- |
P/S (LTM) |
0.04 |
EPS (LTM) |
-7.32 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Co-Diagnostics
CODX
|
$ 1.6 | -3.03 % | $ 2.13 M | Nasdaq Capital Market | USA |
 |
Agilent Technologies
A
|
$ 114.83 | -0.68 % | $ 34.9 B | NYSE,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 24.69 | -1.18 % | $ 686 M | Nasdaq Global Market,SPB | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Illumina
ILMN
|
$ 126.51 | -1.57 % | $ 20.1 B | Nasdaq Global Select Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 21.98 | 0.59 % | $ 1.17 B | Nasdaq Global Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 83.3 | -0.97 % | $ 5.62 B | Nasdaq Global Select Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 15.33 | -1.73 % | $ 464 M | Nasdaq Global Market | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
National Research Corporation
NRC
|
$ 16.92 | -1.11 % | $ 379 M | Nasdaq Global Select Market | USA |
 |
Charles River Laboratories International
CRL
|
$ 165.87 | -3.13 % | $ 8.22 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 27.05 | -1.78 % | $ 20 B | NYSE |  Niderland |
 |
Guardant Health
GH
|
$ 82.95 | -6.27 % | $ 10.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Precipio
PRPO
|
$ 31.65 | 3.09 % | $ 50.8 M | Nasdaq Global Select Market | USA |
 |
Personalis
PSNL
|
$ 5.5 | -7.75 % | $ 326 M | Nasdaq Global Select Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Interpace Biosciences
IDXG
|
$ 1.93 | - | $ 8.54 M | Nasdaq Global Select Market | USA |
 |
Senseonics Holdings
SENS
|
$ 7.17 | -1.44 % | $ 299 M | NYSE American | USA |
 |
Medpace Holdings
MEDP
|
$ 411.6 | -2.32 % | $ 11.9 B | Nasdaq Global Select Market,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Biomerica
BMRA
|
$ 2.19 | 0.46 % | $ 5.03 M | Nasdaq Capital Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 101.98 | -1.19 % | $ 8.41 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Thermo Fisher Scientific
TMO
|
$ 471.36 | 0.71 % | $ 178 B | NYSE,SPB | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 260.02 | -1.29 % | $ 21.6 B | NYSE,SPB | USA |
 |
Trinity Biotech plc
TRIB
|
$ 0.61 | -5.2 % | $ 61.9 M | Nasdaq Global Select Market | Irlanda |
 |
Neogen Corporation
NEOG
|
$ 9.24 | -2.22 % | $ 2 B | Nasdaq Global Select Market,SPB | USA |
 |
Celcuity
CELC
|
$ 120.62 | -4.03 % | $ 5.64 B | Nasdaq Global Select Market | USA |
 |
Twist Bioscience Corporation
TWST
|
$ 59.61 | -2.2 % | $ 3.57 B | Nasdaq Global Select Market,SPB | USA |
 |
NeoGenomics
NEO
|
$ 8.97 | 4.17 % | $ 1.15 B | Nasdaq Global Select Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 4.88 | 0.93 % | $ 452 M | Nasdaq Global Select Market,SPB | USA |
 |
Natera
NTRA
|
$ 200.99 | -1.67 % | $ 19.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 194.95 | -0.85 % | $ 21.6 B | NYSE,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.